Federal Register / Vol. 71, No.
235 / Thursday, December 7, 2006 / Notices
Drug
Lysergic Acid Diethylamide (7315) ...
Tetrahydrocannabinol (7370) ............
Alphamethadol (9605) .......................
Phencyclidine (7471) .........................
Ecgonine (9180) ................................
Methadone (9250) .............................
Morphine (9300) ................................
The company plans to manufacture
small quantities of listed controlled
substances for use in diagnostic
products.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Roche Diagnostics Operations, Inc. to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Roche Diagnostics
Operations, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–20697 Filed 12–6–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated August 14, 2006 and
published in the Federal Register on
August 21, 2006, (71 FR 48556–48557),
Sigma Aldrich Manufacturing LLC.,
Subsidiary of Sigma Aldrich
Manufacturing Company, 3500 Dekalb
Street, St. Louis, Missouri 63118, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule I and II:
VerDate Aug<31>2005 18:18 Dec 06, 2006 Jkt 211001
70989
Sched- Drug Schedule The company plans to import the
ule listed controlled substances for sale to
Cathinone (1235) .......................... I research facilities for drug testing and
I Methcathinone (1237) .................. I analysis.
I Aminorex (1585) ........................... I No comments or objections have been
I Gamma Hydroxybutyric Acid I received. DEA has considered the
II (2010). factors in 21 U.S.C. 823(a) and 952(a)
II Methaqualone (2565) ................... I and determined that the registration of
II Ibogaine (7260) ............................ I
Lysergic acid diethylamide (7315) I
Sigma Aldrich Manufacturing LLC to
II import the basic classes of controlled
Marihuana (7360) ......................... I
Tetrahydrocannabinols (7370) ..... I substances is consistent with the public
Mescaline (7381) .......................... I interest and with United States
4-Bromo-2,5- I obligations under international treaties,
dimethoxyamphetamine (7391). conventions, or protocols in effect on
4-Bromo-2,5- I May 1, 1971, at this time. DEA has
dimethoxyphenethylamine investigated Sigma Aldrich
(7392).
Manufacturing LLC to ensure that the
4-Methyl-2,5- I company’s registration is consistent
dimethoxyamphetamine (7395).
with the public interest. The
2,5-Dimethoxyamphetamine I
(7396). investigation has included inspection
3,4-Methylenedioxyamphetamine I and testing of the company’s physical
(7400). security systems, verification of the
N-Hydroxy-3,4- I company’s compliance with State and
methylenedioxyamphetamine local laws, and a review of the
(7402). company’s background and history.
3,4–Methylenedioxy-N- I Therefore, pursuant to 21 U.S.C. 952(a)
ethylamphetamine (7404). and § 958(a), and in accordance with 21
3,4– I CFR 1301.34, the above named company
Methylenedioxymethamphetam-
is granted registration as an importer of
ine (MDMA) (7405).
4–Methoxyamphetamine (7411) ... I the basic classes of controlled
substances listed.
Bufotenine (7433) ......................... I
Diethyltryptamine (7434) .............. I Dated: November 28, 2006.
Dimethyltryptamine (7435) ........... I Joseph T. Rannazzisi,
Psilocybin (7437) .......................... I
Deputy Assistant Administrator, Office of
Psilocyn (7438) ............................. I
Diversion Control, Drug Enforcement
N-Ethyl-1-phenylcyclohexylamine I
Administration.
(7455).
N-Benzylpiperazine (BZP) (7493) I [FR Doc. E6–20742 Filed 12–6–06; 8:45 am]
Trifluoromethylphenyl) Piperazine I BILLING CODE 4410–09–P
(7494).
Heroin (9200) ............................... I
Normorphine (9313) ..................... I DEPARTMENT OF JUSTICE
Etonitazene (9624) ....................... I
Amphetamine (1100) .................... II Drug Enforcement Administration
Methamphetamine (1105) ............ II
Methylphenidate (1724) ................ II Manufacturer of Controlled
Amobarbital (2125) ....................... II Substances; Notice of Registration
Pentobarbital (2270) ..................... II
Secobarbital (2315) ...................... II By Notice dated July 10, 2006, and
Glutethimide (2550) ...................... II published in the Federal Register on
Nabilone (7379) ............................ II July 24, 2006, (71 FR 41838–41839),
Phencyclidine (7471) .................... II Sigma Aldrich Research BioChemicals,
Cocaine (9041) ............................. II Inc., 1–3 Strathmore Road, Natick,
Codeine (9050) ............................. II Massachusetts 01760, made application
Diprenorphine (9058) ................... II by renewal to the Drug Enforcement
Oxycodone (9143) ........................ II Administration (DEA) to be registered as
Hydromorphone (9150) ................ II
Diphenoxylate (9170) ................... II
a bulk manufacturer of the basic classes
Ecgonine (9180) ........................... II of controlled substances listed in
schedule I and II:
Ethylmorphine (9190) ................... II
Hydrocodone (9193) ..................... II
Levorphanol (9220) ...................... II Drug Schedule
Meperidine (9230) ........................ II
Methadone (9250) ........................ II Cathinone (1235) ............... I
Dextropropoxyphene, bulk (non- II Methcathinone (1237) ........ I
dosage forms) (9273). Aminorex (1585) ................ I
Morphine (9300) ........................... II Alpha-ethyltryptamine I
(7249).
Thebaine (9333) ........................... II
Opium powdered (9639) .............. II Lysergic acid diethylamide I
(7315).
Oxymorphone (9652) ................... II
Tetrahydrocannabinols I
Fentanyl (9801) ............................ II
(7370).
PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\07DEN1.SGM 07DEN1
 70990 Federal Register / Vol. 71, No. 235 / Thursday, December 7, 2006 / Notices
Drug
4–Bromo–2,5–
dimethoxyampheta- mine
(7391).
4–Bromo-2,5-
dimethoxyphenethylami-
ne (7392).
2,5–Dimethoxyampheta-
mine (7396).
3,4–
Methylenedioxyampheta-
mine (7400).
N-Hydroxy-3,4-
methylenedioxyampheta-
mine (7402).
3,4–Methylenedioxy-N-
ethylamphetamine
(7404).
3,4–Methylenedioxymeth-
amphetamine (MDMA)
(7405).
1–[1–(2–
Thieny-
l)cyclohexyl]piperidine
(TCP) (7470).
1–Benzylpiperazine (BZP)
(7493).
Heroin (9200) .....................
Normorphine (9313) ..........
Amphetamine (1100) .........
Methamphetamine (1105)
Nabilone (7379) .................
1–Phenylcyclohexylamine
(7460).
Phencyclidine (7471) .........
Cocaine (9041) ..................
Codeine (9050) ..................
Diprenorphine (9058) .........
Ecgonine (9180) ................
Levomethorphan (9210) ....
Levorphanol (9220) ...........
Meperidine (9230) .............
Metazocine (9240) .............
Methadone (9250) .............
Morphine (9300) ................
Thebaine (9333) ................
Levo-alphacetylmethadol
(9648).
Carfentanil (9743) ..............
Fentanyl (9801) .................
The company plans to manufacture
reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Sigma Aldrich Research BioChemicals,
Inc. to manufacture the listed basic
classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Sigma
Aldrich Research BioChemicals, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
VerDate Aug<31>2005 18:18 Dec 06, 2006
Schedule the above named company is granted
registration as a bulk manufacturer of
I the basic classes of controlled
substances listed.
I Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
I Diversion Control, Drug Enforcement
Administration.
I [FR Doc. E6–20737 Filed 12–6–06; 8:45 am]
BILLING CODE 4410–09–P
I the Drug Enforcement Administration
DEPARTMENT OF JUSTICE
I Etorphine Hydrochloride (9059), a basic
Drug Enforcement Administration
I Importer of Controlled Substances;
Notice of Registration
I By Notice dated July 10, 2006, and
published in the Federal Register on
July 24, 2006, (71 FR 41839–41840),
Stepan Company, Natural Products
I Department, 100 W. Hunter Avenue,
Maywood, New Jersey 07607, made
I
I
application by renewal to the Drug
II Enforcement Administration (DEA) to
II be registered as an importer of Coca
II Leaves (9040), a basic class of controlled
II substance listed in schedule II.
The company plans to import the
II listed controlled substance for the
II
II
manufacture of bulk controlled
II substances and distribution to its
II customers.
II No comments or objections have been
II received. DEA has considered the
II factors in 21 U.S.C. 823(a) and 952(a)
II and determined that the registration of
II
II
Stepan Company to import this basic
II class of controlled substance is
II consistent with the public interest and
with United States obligations under
II international treaties, conventions, or
II protocols in effect on May 1, 1971, at
this time. DEA has investigated Stepan
Company to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security system, verification of
the company’s compliance with State
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–20748 Filed 12–6–06; 8:45 am]
BILLING CODE 4410–09–P
Jkt 211001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 E:\FR\FM\07DEN1.SGM
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated August 15, 2006 and
published in the Federal Register on
August 22, 2006, (71 FR 48948),
Wildlife Laboratories, Inc., 1401 Duff
Drive, Suite 400, Fort Collins, Colorado
80524, made application by renewal to
(DEA) to be registered as an importer of
class of controlled substance listed in
schedule II.
The company plans to import the
listed controlled substance for sale to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Wildlife Laboratories, Inc. to import the
basic class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Wildlife
Laboratories, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–20741 Filed 12–6–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OMB Number 1121–0309]
Agency Information Collection
Activities: Proposed Collection;
Comments Requested
ACTION: 60-Day Notice of Information
Collection Under Review: International
Terrorism Victim Expense
Reimbursement Program Application.
07DEN1